A detailed history of Amalgamated Bank transactions in Cor Medix Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,929 shares of CRMD stock, worth $23,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,929
Previous 1,929 -0.0%
Holding current value
$23,128
Previous $8,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.08 - $6.39 $1,734 - $2,715
425 Added 28.26%
1,929 $8,000
Q1 2024

Apr 23, 2024

SELL
$2.94 - $4.24 $13,635 - $19,665
-4,638 Reduced 75.51%
1,504 $6,000
Q4 2023

Feb 06, 2024

SELL
$3.0 - $4.01 $1,344 - $1,796
-448 Reduced 6.8%
6,142 $23,000
Q2 2023

Aug 11, 2023

BUY
$3.94 - $5.8 $25,964 - $38,222
6,590 New
6,590 $26,000
Q2 2022

Aug 15, 2022

SELL
$2.73 - $5.61 $12,959 - $26,630
-4,747 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$3.83 - $6.24 $18,181 - $29,621
4,747 New
4,747 $26,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $494M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.